Patents Assigned to Interpharm Laboratories Ltd.
  • Bioreactor
    Patent number: 5705390
    Abstract: A radial flow bioreactor comprising a reaction vessel having an inlet and an outlet respectively for adding and withdrawing a culture medium and at least one cell basket within the reaction vessel for accommodating a plurality of cell carriers and having side wall perforations so dimensioned as to prevent passage of the cell carriers therethrough.
    Type: Grant
    Filed: April 14, 1995
    Date of Patent: January 6, 1998
    Assignee: InterPharm Laboratories Ltd.
    Inventors: Avinoam Kadouri, Yehoshua Aloni, Mordechai Geron
  • Serum free medium
    Patent number: 5641647
    Abstract: A serum free medium capable of supporting production of mammalian cell products is provided. The medium comprises a basic medium and a cell viability protection agent, insulin and thrombin or a thrombin receptor activator.
    Type: Grant
    Filed: August 24, 1993
    Date of Patent: June 24, 1997
    Assignee: Interpharm Laboratories Ltd.
    Inventors: Dina Fischer, Moshe Bracha
  • Use of human interferon-beta for stimulation of erythropoiesis
    Patent number: 5104653
    Abstract: Interferon-beta, preferably in low doses, is used for stimulation of erythropoiesis in disorders characterized by lack of maturation of progenitor blood cells to red cells.
    Type: Grant
    Filed: March 16, 1990
    Date of Patent: April 14, 1992
    Assignees: Interpharm Laboratories Ltd., Ramot, University Authority for Applied Research and Industrial Development Ltd.
    Inventor: Rita Michalevicz
  • Complement-dependent cytolytic anti-Trichomonas vaginalis monoclonal antibodies
    Patent number: 5004694
    Abstract: Novel monoclonal antibodies specific to Trichomonas vaginalis, having complement--fixing ability and lysing Trichomonas vaginalis in the presence of complement are disclosed and may be used in therapy and diagnosis of trichomoniasis. Hybridomas producing and compositions comprising these antibodies are also disclosed.
    Type: Grant
    Filed: September 4, 1987
    Date of Patent: April 2, 1991
    Assignee: Interpharm Laboratories Ltd.
    Inventors: Neomi Moay, Enrica Draghi